More than 3,100 cases of the drug-resistant and potentially deadly fungus Candida auris have been reported across 27 states this year, according to data from the Centers for Disease Control and Prevention. The nationwide total through the week ending July 25 runs nearly in line with the 3,348 infections tracked during the same period last … Read more
During a recent hot spell that saw parts of Ireland climb to over 30 degrees, healthcare workers and patients in poorly equipped hospitals, clinics, and nursing homes experienced searing temperatures, leading to unusual rashes, fainting, and difficult working conditions, according to doctors and nurses. Cashel Older Persons Residential Services Heat Conditions Nurse Alice Carew, who … Read more
Research published in the journal Cell reveals that severe COVID-19 cases are often linked to pre-existing autoantibodies that neutralize type I interferons. According to findings from a global consortium of researchers, these autoantibodies are produced by a mature population of B cells that exist before viral exposure, effectively disabling the body’s primary antiviral alarm system. … Read more
UTMB fired a contract nurse following a viral video that suggested she would avoid treating patients who watch Fox News. The University of Texas Medical Branch confirmed the termination on July 3, 2026, stating the employee’s actions contradicted the institution’s commitment to providing unbiased, compassionate care to every patient. What triggered the UTMB investigation? The … Read more
The FDA’s approval of the Wegovy oral semaglutide pill in late December 2025 offers a needle-free weight management option, though it requires more rigorous dosing than the injectable version. According to Dr. Anthony Puopolo, Chief Medical Officer at LifeMD, the pill delivers the same molecule as the shot but faces biological barriers that demand strict … Read more
Beyond the Needle: The Future of Weight Management and the Oral Semaglutide Shift The landscape of metabolic health is shifting beneath our feet. With the FDA’s approval of oral semaglutide, the conversation has moved from “Can I lose weight?” to “How do I maintain this safely for the long haul?” As an industry observer who … Read more
The Price Drop: How Generics Are Changing the GLP-1 Landscape For years, semaglutide—the active ingredient in brand-name drugs like Ozempic and Wegovy—has been whispered about in celebrity circles and sought after in clinics across Canada. But for many, the “miracle drug” came with a prohibitive price tag, often ranging from $200 to over $450 per … Read more
The Alzheimer’s Blood Test Dilemma: Hope, Hype, and What It Means for You The promise is compelling: a simple blood test, administered even before symptoms appear, could reveal your future risk of developing Alzheimer’s disease. But as these tests become more readily available, a crucial question arises – should you acquire tested, and what would … Read more
Beyond the Scale: The Long-Term Reality of GLP-1s For many, medications like Ozempic, Wegovy, and Mounjaro have felt like a miracle for weight management. However, a critical shift is occurring in how medical experts view these tools. Rather than seeing them as short-term solutions, the trend is moving toward treating GLP-1s as long-term interventions. View … Read more
The Rising Tide of Perimenopause Awareness: A Critical Look at Medicalization and the Future of Women’s Health A new film, “The M Factor 2: Before the Pause,” premiering on PBS, is sparking debate about the increasing medicalization of perimenopause. Following its predecessor, “The M Factor,” this sequel focuses on the often-overlooked transition that can start … Read more